- Home
- SPNS vs CNTA Comparison
SPNS vs CNTA Comparison
Compare SPNS & CNTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SPNS
- CNTA
- Stock Information
- Founded
- SPNS 1982
- CNTA 2020
- Country
- SPNS Israel
- CNTA United Kingdom
- Employees
- SPNS N/A
- CNTA N/A
- Industry
- SPNS Computer Software: Prepackaged Software
- CNTA Biotechnology: Pharmaceutical Preparations
- Sector
- SPNS Technology
- CNTA Health Care
- Exchange
- SPNS Nasdaq
- CNTA Nasdaq
- Market Cap
- SPNS 1.6B
- CNTA 1.6B
- IPO Year
- SPNS 1992
- CNTA 2021
- Fundamental
- Price
- SPNS $30.14
- CNTA $14.00
- Analyst Decision
- SPNS Buy
- CNTA Strong Buy
- Analyst Count
- SPNS 4
- CNTA 10
- Target Price
- SPNS $34.25
- CNTA $28.78
- AVG Volume (30 Days)
- SPNS 159.2K
- CNTA 1.1M
- Earning Date
- SPNS 07-31-2025
- CNTA 08-12-2025
- Dividend Yield
- SPNS 2.02%
- CNTA N/A
- EPS Growth
- SPNS 11.11
- CNTA N/A
- EPS
- SPNS 1.30
- CNTA N/A
- Revenue
- SPNS $544,235,000.00
- CNTA $15,000,000.00
- Revenue This Year
- SPNS $8.30
- CNTA N/A
- Revenue Next Year
- SPNS $7.42
- CNTA N/A
- P/E Ratio
- SPNS $22.93
- CNTA N/A
- Revenue Growth
- SPNS 3.84
- CNTA 118.88
- 52 Week Low
- SPNS $23.69
- CNTA $8.76
- 52 Week High
- SPNS $41.22
- CNTA $19.09
- Technical
- Relative Strength Index (RSI)
- SPNS 62.48
- CNTA 59.61
- Support Level
- SPNS $29.50
- CNTA $13.22
- Resistance Level
- SPNS $30.39
- CNTA $14.14
- Average True Range (ATR)
- SPNS 0.49
- CNTA 0.68
- MACD
- SPNS 0.09
- CNTA 0.10
- Stochastic Oscillator
- SPNS 88.94
- CNTA 86.77
About SPNS Sapiens International Corporation N.V. (Cayman Islands)
Sapiens International Corp NV is a provider of software solutions for the insurance industry, with an emerging focus on the financial services sector. The company offers software, solutions, and professional services for property & casualty (P&C); reinsurance; life, pension & annuity (L&A); workers' compensation (WC); medical professional liability (MPL); financial & compliance (F&C); and decision modeling for both insurance and financial markets. The group also provides services for project delivery and implementation services, for its Software Solutions portfolio. Geographically, it operates in the region of North America, Rest of the World, and Europe. It generates revenue from Europe.
About CNTA Centessa Pharmaceuticals plc
Centessa Pharmaceuticals PLC is a clinical-stage pharmaceutical company. The company's pipeline assets include: SerpinPC for Hemophilia A, B; LB101 for Solid Tumors; ORX750 for Narcolepsy Type 1 (NT1) and other sleep disorders; MGX292 Pulmonary Arterial Hypertension (PAH); and Undisclosed for Solid Tumors.